Markus D. Siegelin

7.0k total citations
109 papers, 4.1k citations indexed

About

Markus D. Siegelin is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Markus D. Siegelin has authored 109 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 34 papers in Genetics and 29 papers in Cancer Research. Recurrent topics in Markus D. Siegelin's work include Glioma Diagnosis and Treatment (34 papers), Cell death mechanisms and regulation (28 papers) and Cancer, Hypoxia, and Metabolism (20 papers). Markus D. Siegelin is often cited by papers focused on Glioma Diagnosis and Treatment (34 papers), Cell death mechanisms and regulation (28 papers) and Cancer, Hypoxia, and Metabolism (20 papers). Markus D. Siegelin collaborates with scholars based in United States, Germany and Switzerland. Markus D. Siegelin's co-authors include Georg Karpel‐Massler, Mike‐Andrew Westhoff, Timo Gaiser, Antje Habel, Alain Borczuk, Dario C. Altieri, Chang Shu, Marc‐Eric Halatsch, Peter Canoll and Jeffrey N. Bruce and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Molecular Cell.

In The Last Decade

Markus D. Siegelin

103 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus D. Siegelin United States 39 2.7k 1.0k 802 786 382 109 4.1k
Mike‐Andrew Westhoff Germany 38 2.5k 0.9× 904 0.9× 803 1.0× 765 1.0× 429 1.1× 102 3.9k
Pixu Liu China 23 3.1k 1.1× 731 0.7× 560 0.7× 1.2k 1.5× 452 1.2× 44 4.4k
Georg Karpel‐Massler Germany 36 1.9k 0.7× 785 0.8× 881 1.1× 565 0.7× 351 0.9× 103 3.1k
Hailing Cheng China 25 3.2k 1.2× 664 0.7× 489 0.6× 1.2k 1.5× 292 0.8× 41 4.3k
Camilla Evangelisti Italy 38 4.5k 1.7× 860 0.9× 516 0.6× 1.4k 1.8× 620 1.6× 90 6.4k
Jörg Bäsecke Germany 22 3.0k 1.1× 669 0.7× 293 0.4× 1.2k 1.5× 395 1.0× 34 4.4k
Sang‐Gu Hwang South Korea 38 2.4k 0.9× 826 0.8× 202 0.3× 913 1.2× 329 0.9× 123 3.9k
Ker Yu United States 36 3.3k 1.2× 570 0.6× 275 0.3× 631 0.8× 477 1.2× 84 4.5k
Michael E. Pacold United States 23 4.1k 1.5× 1.1k 1.1× 252 0.3× 607 0.8× 450 1.2× 36 5.2k
Guangchao Sui United States 35 4.6k 1.7× 1.2k 1.2× 239 0.3× 862 1.1× 501 1.3× 94 6.5k

Countries citing papers authored by Markus D. Siegelin

Since Specialization
Citations

This map shows the geographic impact of Markus D. Siegelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus D. Siegelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus D. Siegelin more than expected).

Fields of papers citing papers by Markus D. Siegelin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus D. Siegelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus D. Siegelin. The network helps show where Markus D. Siegelin may publish in the future.

Co-authorship network of co-authors of Markus D. Siegelin

This figure shows the co-authorship network connecting the top 25 collaborators of Markus D. Siegelin. A scholar is included among the top collaborators of Markus D. Siegelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus D. Siegelin. Markus D. Siegelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schneider, Matthias, Anna‐Laura Potthoff, Georg Karpel‐Massler, et al.. (2024). The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours. Molecular Oncology. 18(12). 2890–2905. 6 indexed citations
2.
3.
Greene, Lloyd A., Qing Zhou, Markus D. Siegelin, & James M. Angelastro. (2023). Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers. Cells. 12(4). 581–581. 19 indexed citations
4.
Kinslow, Connor J., Ali I. Rae, Kekoa Taparra, et al.. (2023). MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas. Clinical Cancer Research. 29(21). 4399–4407. 13 indexed citations
5.
Chung, Kyung Min, Hyunha Kim, Trang Nguyen, et al.. (2022). A systemic cell stress signal confers neuronal resilience toward oxidative stress in a Hedgehog-dependent manner. Cell Reports. 41(3). 111488–111488. 10 indexed citations
6.
Bianchetti, Elena, et al.. (2021). RAB38 Facilitates Energy Metabolism and Counteracts Cell Death in Glioblastoma Cells. Cells. 10(7). 1643–1643. 1 indexed citations
7.
Dwucet, Annika, Varun V. Prabhu, Joshua E. Allen, et al.. (2021). ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression. Frontiers in Cell and Developmental Biology. 9. 734699–734699. 3 indexed citations
8.
Zhang, Yiru, Trang Nguyen, Enyuan Shang, et al.. (2019). MET Inhibition Elicits PGC1α-Dependent Metabolic Reprogramming in Glioblastoma. Cancer Research. 80(1). 30–43. 44 indexed citations
9.
Siegelin, Markus D., Elisabeth Schneider, Mike‐Andrew Westhoff, Christian Rainer Wirtz, & Georg Karpel‐Massler. (2019). Current state and future perspective of drug repurposing in malignant glioma. Seminars in Cancer Biology. 68. 92–104. 40 indexed citations
10.
Zhang, Yiru, Chiaki Tsuge Ishida, Wataru Ishida, et al.. (2018). Combined HDAC and Bromodomain Protein Inhibition Reprograms Tumor Cell Metabolism and Elicits Synthetic Lethality in Glioblastoma. Clinical Cancer Research. 24(16). 3941–3954. 37 indexed citations
11.
Zhang, Yiru, Elena Bianchetti, Chang Shu, et al.. (2018). Metabolic Reprogramming by Dual AKT/ERK Inhibition through Imipridones Elicits Unique Vulnerabilities in Glioblastoma. Clinical Cancer Research. 24(21). 5392–5406. 63 indexed citations
12.
Bianchetti, Elena, et al.. (2018). Usp9X Regulates Cell Death in Malignant Peripheral Nerve Sheath Tumors. Scientific Reports. 8(1). 17390–17390. 13 indexed citations
13.
Karpel‐Massler, Georg, Chiaki Tsuge Ishida, Elena Bianchetti, et al.. (2017). Inhibition of Mitochondrial Matrix Chaperones and Antiapoptotic Bcl-2 Family Proteins Empower Antitumor Therapeutic Responses. Cancer Research. 77(13). 3513–3526. 62 indexed citations
14.
Ishida, Chiaki Tsuge, Elena Bianchetti, Chang Shu, et al.. (2017). BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma. Oncotarget. 8(18). 29558–29573. 36 indexed citations
15.
Karpel‐Massler, Georg, Basil A. Horst, Chang Shu, et al.. (2016). A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers. Clinical Cancer Research. 22(18). 4698–4711. 63 indexed citations
16.
Pareja, Fresia, David MacLeod, Chang Shu, et al.. (2014). PI3K and Bcl-2 Inhibition Primes Glioblastoma Cells to Apoptosis through Downregulation of Mcl-1 and Phospho-BAD. Molecular Cancer Research. 12(7). 987–1001. 72 indexed citations
17.
Siegelin, Markus D. & Alain Borczuk. (2013). Epidermal growth factor receptor mutations in lung adenocarcinoma. Laboratory Investigation. 94(2). 129–137. 187 indexed citations
18.
Siegelin, Markus D., Janet Plescia, Christopher M. Raskett, et al.. (2010). Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma. Molecular Cancer Therapeutics. 9(6). 1638–1646. 34 indexed citations
19.
Ghosh, Jagadish C., Markus D. Siegelin, Takehiko Dohi, & Dario C. Altieri. (2010). Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells. Cancer Research. 70(22). 8988–8993. 150 indexed citations
20.
Siegelin, Markus D., et al.. (2009). Epigenetic Silencing of Death Receptor 4 Mediates Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Resistance in Gliomas. Clinical Cancer Research. 15(17). 5457–5465. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mike‐Andrew Westhoff Breakdown of academic impact, for papers by Pixu Liu Breakdown of academic impact, for papers by Georg Karpel‐Massler Breakdown of academic impact, for papers by Hailing Cheng Breakdown of academic impact, for papers by Camilla Evangelisti Breakdown of academic impact, for papers by Jörg Bäsecke Breakdown of academic impact, for papers by Sang‐Gu Hwang Breakdown of academic impact, for papers by Ker Yu Breakdown of academic impact, for papers by Michael E. Pacold Breakdown of academic impact, for papers by Guangchao Sui
Rankless by CCL
2026